I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Tinker, Anna V
294
results:
Search for persons
X
Format
Online (294)
Mediatypes
E-Books (1)
Articles (Online) (196)
Bookchapter (Online) (5)
OpenAccess-fulltext (92)
Sorted by: Relevance
Sorted by: Year
?
1
Targeting HER2-mutant metastatic cervical cancer with nerat..:
Friedman, Claire F.
;
D'Souza, Anishka
;
Bello Roufai, Diana
...
Gynecologic Oncology. 181 (2024) - p. 162-169 , 2024
Link:
https://doi.org/10.1016/..
?
2
Efficacy and safety of niraparib in patients aged 65 years ..:
Valabrega, Giorgio
;
Pothuri, Bhavana
;
Oaknin, Ana
...
Gynecologic Oncology. 187 (2024) - p. 128-138 , 2024
Link:
https://doi.org/10.1016/..
?
3
Fighting resistance: post-PARP inhibitor treatment strategi..:
Veneziani, Ana C.
;
Scott, Clare
;
Wakefield, Matthew J.
..
Therapeutic Advances in Medical Oncology. 15 (2023) - p. 175883592311576 , 2023
Link:
https://doi.org/10.1177/..
?
4
A Phase Ib Study Assessing the Safety, Tolerability, and Ef..:
Bauer, Todd M.
;
Moore, Kathleen N.
;
Rader, Janet S.
...
Targeted Oncology. 18 (2023) 4 - p. 517-530 , 2023
Link:
https://doi.org/10.1007/..
?
5
A rapidly evolving landscape: immune checkpoint inhibitors ..:
Tinker, Anna V.
;
Dhani, Neesha C.
;
Ghatage, Prafull
...
Therapeutic Advances in Medical Oncology. 15 (2023) - p. 175883592311576 , 2023
Link:
https://doi.org/10.1177/..
?
6
Safety, Efficacy, and Biomarker Analyses of Dostarlimab in ..:
Oaknin, Ana
;
Pothuri, Bhavana
;
Gilbert, Lucy
...
Clinical Cancer Research. 29 (2023) 22 - p. 4564-4574 , 2023
Link:
https://doi.org/10.1158/..
?
7
A plain language summary of results from the GARNET study o..:
Oaknin, Ana
;
Gilbert, Lucy
;
Tinker, Anna V
...
Future Oncology. 19 (2023) 25 - p. 1709-1714 , 2023
Link:
https://doi.org/10.2217/..
?
8
CD8 + T cell infiltration is associated with improved survi..:
Guo, Nancy
;
Yang, Aijun
;
Farooq, Fabiha Binte
...
Scientific Reports. 13 (2023) 1 - p. , 2023
Link:
https://doi.org/10.1038/..
?
9
Survival and modelled cancer antigen-125 ELIMination rate c..:
Corbaux, Pauline
;
You, Benoit
;
Glasspool, Rosalind M.
...
European Journal of Cancer. 191 (2023) - p. 112966 , 2023
Link:
https://doi.org/10.1016/..
?
10
Cervical cancer patient reported gastrointestinal outcomes:..:
Urban, Ryan
;
Wong, Justin
;
Lim, Peter
...
Journal of Gynecologic Oncology. 33 (2022) 5 - p. , 2022
Link:
https://doi.org/10.3802/..
?
11
Treatment and outcomes in undifferentiated and dedifferenti..:
Hamilton, Sarah Nicole
;
Tinker, Anna V.
;
Kwon, Janice
...
Journal of Gynecologic Oncology. 33 (2022) 3 - p. , 2022
Link:
https://doi.org/10.3802/..
?
12
Safety and antitumor activity of dostarlimab in patients wi..:
Oaknin, Ana
;
Gilbert, Lucy
;
Tinker, Anna V
...
Journal for ImmunoTherapy of Cancer. 10 (2022) 1 - p. e003777 , 2022
Link:
https://doi.org/10.1136/..
?
13
Corrigendum to "Low-grade serous carcinoma (LGSC): A Canadi..:
Scott, Stephanie A.
;
Fernandez, Marta Llaurado
;
Kim, Hannah
...
Gynecologic Oncology. 167 (2022) 2 - p. 399 , 2022
Link:
https://doi.org/10.1016/..
?
14
A Pan-Canadian Consensus Statement on First-Line PARP Inhib..:
Tinker, Anna V.
;
Altman, Alon D.
;
Bernardini, Marcus Q.
...
Current Oncology. 29 (2022) 6 - p. 4354-4369 , 2022
Link:
https://doi.org/10.3390/..
?
15
Results of the phase I CCTG IND.231 trial of CX-5461 in pat..:
Hilton, John
;
Gelmon, Karen
;
Bedard, Philippe L.
...
Nature Communications. 13 (2022) 1 - p. , 2022
Link:
https://doi.org/10.1038/..
1-15